SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-241932
Filing Date
2022-09-09
Accepted
2022-09-09 16:02:02
Documents
15
Period of Report
2022-09-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d393975d8k.htm   iXBRL 8-K 25566
2 EX-10.1 d393975dex101.htm EX-10.1 161559
6 GRAPHIC g393975g0901225707329.jpg GRAPHIC 871
7 GRAPHIC g393975g0901225707548.jpg GRAPHIC 1117
  Complete submission text file 0001193125-22-241932.txt   357681

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmea-20220907.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20220907_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20220907_pre.xml EX-101.PRE 11717
9 EXTRACTED XBRL INSTANCE DOCUMENT d393975d8k_htm.xml XML 3459
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 221236045
SIC: 2834 Pharmaceutical Preparations